# EDGAR Filing Document

**Accession Number:** 0000095953
**File Stem:** 0000095953-25-000090
**Filing Date:** 2025-8
**Character Count:** 27213
**Document Hash:** c1115408a918db03d7134858fb1f8757
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000095953-25-000090.hdr.sgml**: 20250826

**ACCESSION NUMBER**: 0000095953-25-000090

**CONFORMED SUBMISSION TYPE**: 8-K

**PUBLIC DOCUMENT COUNT**: 34

**CONFORMED PERIOD OF REPORT**: 20250826

**ITEM INFORMATION**: Regulation FD Disclosure

**ITEM INFORMATION**: Financial Statements and Exhibits

**FILED AS OF DATE**: 20250826

**DATE AS OF CHANGE**: 20250826

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ASCENT INDUSTRIES CO.
- **CENTRAL INDEX KEY:** 0000095953
- **STANDARD INDUSTRIAL CLASSIFICATION:** CHEMICALS & ALLIED PRODUCTS [2800]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 570426694
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 8-K
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-05200
- **FILM NUMBER:** 251257652

**BUSINESS ADDRESS:**
- **STREET 1:** 20 N. MARTINGALE RD
- **STREET 2:** SUITE 430
- **CITY:** SCHAUMBURG
- **STATE:** IL
- **ZIP:** 60173
- **BUSINESS PHONE:** 6308849181

**MAIL ADDRESS:**
- **STREET 1:** 20 N. MARTINGALE RD
- **STREET 2:** SUITE 430
- **CITY:** SCHAUMBURG
- **STATE:** IL
- **ZIP:** 60173

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SYNALLOY CORP
- **DATE OF NAME CHANGE:** 19920703

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** BLACKMAN UHLER INDUSTRIES INC
- **DATE OF NAME CHANGE:** 19710510

?xml version='1.0' encoding='ASCII'? acnt-20250826

**UNITED STATES**

**SECURITIES AND EXCHANGE COMMISSION**

**WASHINGTON D.C. 20549**

**FORM 8-K** 

**CURRENT REPORT**

**PURSUANT TO SECTION 13 OR 15(D) OF THE**

**SECURITIES EXCHANGE ACT OF 1934**

Date of Report (Date of earliest event reported): August 26, 2025

![Ascent Logo.jpg](acnt-20250826_g1.jpg)

**<u>Ascent Industries Co.</u>**

*(Exact name of registrant as specified in its charter)*

---

| | | | | |
|:---|:---|:---|:---|:---|
| **Delaware** | **Delaware** | **0-19687** | **0-19687** | **57-0426694** |
| *(State or other jurisdiction of incorporation or organization)* | *(State or other jurisdiction of incorporation or organization)* | (Commission File Number) | (Commission File Number) | *(I.R.S. Employer Identification No.)* |
| **20 N. Martingale Rd,** | **Suite 430,** |  |  |  |
| **Schaumburg,** | **Illinois** |  |  | **60173** |
| *(Address of principal executive offices)* | *(Address of principal executive offices)* |  |  | *(Zip Code)* |
|  |  | **(630)** | **884-9181** |  |
|  |  | *(Registrant's telephone number, including area code)* | *(Registrant's telephone number, including area code)* |  |
| **Inapplicable** | **Inapplicable** | **Inapplicable** | **Inapplicable** | **Inapplicable** |
| (Former name or former address if changed since last report) | (Former name or former address if changed since last report) | (Former name or former address if changed since last report) | (Former name or former address if changed since last report) | (Former name or former address if changed since last report) |

---

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐&nbsp;&nbsp;&nbsp;&nbsp;Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐&nbsp;&nbsp;&nbsp;&nbsp;Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐&nbsp;&nbsp;&nbsp;&nbsp;Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

---

| | | |
|:---|:---|:---|
| **<u>Title of each class</u>** | **<u>Trading Symbol</u>** | **<u>Name of exchange on which registered</u>** |
| Common Stock, par value $1.00 per share | ACNT | NASDAQ Global Market |

---

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

    

------

**Item 7.01&nbsp;&nbsp;&nbsp;&nbsp;Regulation FD Disclosure.**

On August 26, 2025, representatives of the Company will make a presentation to investors using slides containing the information attached to this Current Report on Form 8-K as Exhibit 99.1 (the "Investor Presentation") and incorporated herein by reference.

The Investor Presentation includes financial information not prepared in accordance with generally accepted accounting principles ("Non-GAAP Financial Measures"). A reconciliation of the Non-GAAP Financial Measures to financial information prepared in accordance with generally accepted accounting principles ("GAAP"), as required by Regulation G, is included within Exhibit 99.1 to this Current Report on Form 8-K. The Company is providing disclosure of the reconciliation of reported Non-GAAP Financial Measures used in the Investor Presentation, among other places, to its comparable financial measures on a GAAP basis. The Company believes that the Non-GAAP Financial Measures provide investors additional ways to view our operations, when considered with both our GAAP results and the reconciliation to net income and net cash provided by operating activities, which we believe provide a more complete understanding of our business than could be obtained absent this disclosure. We believe the Non-GAAP Financial Measures also provide investors a useful tool to assess shareholder value.

By filing this Current Report on Form 8-K and furnishing the information contained herein, the Company makes no admission as to the materiality of any information in this report that is required to be disclosed solely by reason of Regulation FD.

The information contained in the Investor Presentation is summary information that is intended to be considered in the context of the Company's Securities and Exchange Commission ("SEC") filings and other public announcements that the Company may make, by press release or otherwise, from time to time. The Company undertakes no duty or obligation to publicly update or revise the information contained in this report, although it may do so from time to time as its management believes is warranted. Any such updating may be made through the filing of other reports or documents with the SEC, through press releases or through other public disclosure.

The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.

**Item 9.01.&nbsp;&nbsp;&nbsp;&nbsp;Financial Statements and Exhibits**

(d) Exhibits

---

| | |
|:---|:---|
| <u>Exhibit Number</u> | <u>Description of Exhibit</u> |
| <u>[99.1](acntir_16thannualmidwest.htm)</u> | <u>[Investor Presentation dated August 26, 2025](acntir_16thannualmidwest.htm)</u> |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document) |

---

------

**SIGNATURE**

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on behalf by the undersigned hereunto duly authorized.

---

| | |
|:---|:---|
| | **Ascent Industries Co.** |
| Dated: August 26, 2025 | By: /s/ Ryan Kavalauskas |
|  | Ryan Kavalauskas |
|  | Chief Financial Officer |

---

## Exhibit 99.1

![](acntir_16thannualmidwest001.jpg)

16th Annual MIDWEST IDEAS Conference August 26, 2025 Ascent Industr ies Co. \| Nasdaq: ACNT

------

![](acntir_16thannualmidwest002.jpg)

Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995 and other applicable federal securities laws. All statements that are not historical facts are forward-looking statements. Forward looking statements can be identified through the use of words such as "estimate," "project," "intend," "expect," "believe," "should," "anticipate," "hope," "optimistic," "plan," "outlook," "should," "could," "may" and similar expressions. The forward-looking statements are subject to certain risks and uncertainties, including without limitation those identified below, which could cause actual results to differ materially from historical results or those anticipated. Readers are cautioned not to place undue reliance on these forward-looking statements. The following factors could cause actual results to differ materially from historical results or those anticipated: adverse economic conditions, including risks relating to the impact and spread of and the government's response to pandemics; inability to weather an economic downturn; the impact of competitive products and pricing; product demand and acceptance risks; raw material and other increased costs, including the impact of tariffs; raw material availability; financial stability of the Company's customers; customer delays or difficulties in the production of products; loss of consumer or investor confidence; employee relations; ability to maintain workforce by hiring trained employees; labor efficiencies; risks associated with acquisitions; environmental issues; negative or unexpected results from tax law changes; inability to comply with covenants and ratios required by the Company's debt financing arrangements; and other risks detailed from time-to-time in Ascent Industries Co.'s Securities and Exchange Commission filings, including our Annual Report on Form 10-K, which filings are available from the SEC. Ascent Industries Co. assumes no obligation to update any forward-looking information included in this release. Non-GAAP Financial Information Financial statement information included in this earnings release includes non-GAAP (Generally Accepted Accounting Principles) measures and should be read along with the accompanying tables which provide a reconciliation of non-GAAP measures to GAAP measures. Adjusted EBITDA is a non-GAAP financial measure that the Company believes is useful to investors in evaluating its results to determine the value of a company. An item is excluded in the measure if its periodic value is inconsistent and sufficiently material that not identifying the item would render period comparability less meaningful to the reader or if including the item provides a clearer representation of normalized periodic earnings. The Company excludes in Adjusted EBITDA two categories of items: 1) Base EBITDA components, including: interest expense, income taxes, depreciation and amortization, and 2) Material transaction costs including: goodwill impairment, asset impairment, gain on lease modification, stock-based compensation, non-cash lease cost, acquisition costs and other fees, shelf registration costs, loss on extinguishment of debt, retention costs and restructuring & severance costs from net income. Management believes that these non-GAAP measures are useful because they are key measures used by our management team to evaluate our operating performance, generate future operating plans and make strategic decisions as well as allow readers to compare the financial results between periods. Non-GAAP measures should not be considered as an alternative to any measure of performance or financial condition as promulgated under GAAP, and investors should consider the Company's performance and financial condition as reported under GAAP and all other relevant information when assessing the performance or financial condition of the Company. Non-GAAP measures have limitations as analytical tools, and investors should not consider them in isolation or as a substitute for analysis of the Company's results or financial condition as reported under GAAP. Forward Looking Statement Safe Harbor and Non-GAAP Information 2

------

![](acntir_16thannualmidwest003.jpg)

2025 Stabilized, Transformed, & Executing

------

![](acntir_16thannualmidwest004.jpg)

Kitchen, Kavalauskas, and many of their management team counterparts have previously worked together, a synergy that has had an undeniable impact on Ascent's operational and financial performance since assuming their roles in early 2024 CEO & CFO Have a Proven Track Record of Making Good Specialty Chemical Companies Great Bryan Kitchen President & Chief Executive Officer  Bryan joined Ascent in September 2023 to lead the specialty chemicals segment; promoted to president & CEO in February 2024  Prior to joining Ascent, Bryan led the stabilization, turnaround and successful sale of Clearon Corp to Solenis Previous experience: Ryan Kavalauskas Chief Financial Officer  Ryan joined Ascent as CFO in February 2024  Prior to joining Ascent, Ryan was the CFO at Clearon and played an instrumental role in the stabilization, turnaround and successful sale of Clearon Corp to Solenis Previous Experience: Built to deliver durable shareholder value. Led by those who've done it before, together. $19.9M YoY Increase / 125% Increase in Adjusted EBITDA $35.9M YoY Decrease / 19% Reduction in COGS $20.5M YoY Increase / 1,349% Increase in Gross Profit Transformational Results in 2024 $17M Cash from Continuing Operations Synergistic CEO & CFO installed early 2024 New Management Team established in 2024, reuniting a proven leadership dynamic and restoring a trusted bench Results representative of Continuing Operations as of 12/31/2024

------

![](acntir_16thannualmidwest005.jpg)

After 75 years, we are going back to our roots as a Specialty Chemical Company Company Founded Blackman Uhler Industries, Inc. was founded in 1945, marking the company's entry into the specialty chemical market. Bristol Metals Blackman Uhler Industries, Inc. acquired Bristol Metals, initiating the company's expansion into the stainless- steel industry and further diversifying its operations. Synalloy Corporation Blackman Uhler Industries Inc., changes name to Synalloy Corporation. Initial Public Offering Synalloy Corporation launched its initial public offering on the NASDAQ Stock Exchange, trading under the ticker symbol SYNL. Manufacturers Chemicals Synalloy Corporation acquires Manufacturers Chemicals, significantly expanding the company's footprint in the specialty chemicals sector and diversifying its product offering Rite Industries Synalloy Corporation combined its textile dyes business with Rite Industries to form a new subsidiary, Blackman Uhler Specialties. Palmer of Texas Tanks Synalloy Corporation acquired Palmer of Texas Tanks, a premier manufacturer of fiberglass and stainless storage tanks used primarily in the oil industry. CRI Tolling In line with its long- term commitment to the chemical industry, Synalloy Corporation acquired CRI Tolling, marking its first foray into specialty chemical custom manufacturing. Specialty Pipe & Tube Synalloy Corporation advanced its vertical integration and expanded its metals business by acquiring Specialty Pipe & Tube and the U.S. assets of Marcegaglia in 2014. Marcegaglia USA Further expanding its metal business, in 2016, Synalloy Corporation acquired the stainless-steel pipe and tube assets of Marcegaglia USA. Marcegaglia USA Synalloy Corporation made yet another acquisition acquiring the galvanized pipe and tube assets of Marcegaglia USA. American Stainless Tubing, Inc. Synalloy Corporation further diversified through the acquisition of American Stainless Tubing Inc., a leading manufacturer of ornamental stainless- steel tubing. DanChem Technologies Expanding on its presence in specialty chemicals custom manufacturing, Synalloy Corporation acquired DanChem Technologies in 2021 from Edgewater Capital Partners. Ascent Industries Co. Synalloy Corporation rebranded to Ascent Industries Co., trading on the NASDAQ Stock Exchange under the ticker symbol ACNT. Divestiture of Specialty Pipe & Tube Executing against its strategic plan, Ascent sold the business and related assets of Specialty Pipe & Tube to a Financial Sponsor. Portfolio Optimization Ascent sells substantially all operating assets associated with the Tubular segment Munhall is the final EBITDA drag in the portfolio 1945 1964 1967 1980 1996 2003 2012 2013 2014 2016 2018 2019 2021 2022 2023 2025 Re-shoring & Near-Shoring Trends \| Stable, Recurrent Demand \| Customized, Value-Added Solutions \| Supply Chain Resilience 2024 Management Turnaround Kitchen & Kavalauskas installed as CEO and CFO respectively; high-impact team was assembled to accelerate transformation and unlock shareholder value

------

![](acntir_16thannualmidwest006.jpg)

Expand and Elevate our Current Capabilities Maximizing our owned assets to serve high-value segments like Oil & Gas, CASE, HI&I, Water Treatment and Ag with precision & technical support Our Strategy & Operating Model Outcomes over everything. We're building a platform that solves real problems across the value chain, not just by providing products or capacity, but by offering a full suite of services: formulation development, reaction capabilities, blending, packaging, logistics, regulatory support and reliable delivery. Executed through three core levers: 6 Build an Integrated Value Chain Through acquisitions of regional distributors, formulation labs and specialty or intermediate manufacturers where owning production improves cost, flexibility or service Win Across the Moments that Matter Moments where loyalty is earned, and retained: 1. Discovery & Development 2. Commercial & Contracting 3. Manufacturing & Fulfillment 4. Service & Lifecycle Support It's not a tagline, it's a strategic roadmap.

------

![](acntir_16thannualmidwest007.jpg)

Buy, Build & Operate Custom Manufacturing Toll ManufacturingProducts Formulation CustomizationRegulatoryLogisticsWarehousingBlendingReactionScale-Up Primary Development 3 Domestic Manufacturing Sites 5 Manufacturing Plants 95% Revenue Supported With Domestic Raw Materials Ascent (CaaS Model) Toll Manufactures Distributors Custom Manufacturers B U S I N E S S M O D E LS O L U T I O N S 1945 Founded 205 Employees 170+ Customers Execute a customer-centric chemical supply chain model that fuses development, scale-up, manufacturing (small batch & continuous), compliance and distribution into a unified offering We connect with customers the way they want: when, where, and how they choose. We win across the Moments that Matter [Development, Contracting, Manufacturing & Fulfillment and Service] What We Do How We Win Integrated Capabilities and Agile Business Models for Superior Customer Outcomes Chemical Manufactures $80.8M 2024 Revenue

------

![](acntir_16thannualmidwest008.jpg)

Household, Industrial, and Institutional (HI&I) Cleaning $25 BN TAM \| 4-5% CAGR $15 BN TAM \| 4-5% CAGR Oil & Gas Water Treatment CASE Textiles LubricantsPulp & Paper $40 BN TAM \| 6-8.5-6% CAGR $10 BN TAM \| 2.5-3.5% CAGR $20 BN TAM \| 4.5-5.5% CAGR $4 BN TAM \| 2-2.5% CAGR $6 BN TAM \| 3.5-4.5% CAGR Performance MaterialsLife Sciences Agriculture Personal Care $15 BN TAM \| 5-6% CAGR $33 BN TAM \| 2% CAGR Guided by customer needs, we deliver tailored specialty-chemistry solutions at scale across an array of high-value segments 8

------

![](acntir_16thannualmidwest009.jpg)

$1.14 $1.74 2024 Custom Manufacturing Proprietary Products While filling the plants with higher margin business that is more predictable and reliable Portfolio Defined, Refined & Rebranded \*Excludes volume, revenue & margin from exclusive use manufacturing operations Sales Volume\* Average Selling Price\* Gross Margin\* 9 15% 23% 2023 2024 Proprietary Products 53% Increase 52% Favorable 25% 31% 2024 Custom Manufacturing Proprietary Products 24% Favorable

------

![](acntir_16thannualmidwest010.jpg)

Ample, underutilized capacity provides a capital-light, low-risk foundation for outsized growth Requiring minimal capital reinvestment to support growth $1.3 $1.6 $1.4 $1.6 2022 2023 2024 Danville, VA Fountain Inn, SC Cleveland, TN MM USD 2025E Within an asset base capable of supporting significant growth with minimal capital reinvestment

------

![](acntir_16thannualmidwest011.jpg)

Inflection Point: Foundation Laid, Growth Ahead 24% Reduction in COGS YoY 1H Decrease / $9.0M 77% Increase in Adj. EBITDA YoY 1H Increase / $2.6M $56M Proceeds Generated Bristol & ASTI Asset Sale – pre – NWC true-up 20% Reduction in Inventory YoY 1H Decrease / $1.7M 1H Results from Continuing Operations 11 Strong Balance Sheet and Driving Transformational Change

------

![](acntir_16thannualmidwest012.jpg)

2025-2030 Durable Earnings-Growth Growth & Catalysts

------

![](acntir_16thannualmidwest013.jpg)

Portfolio Optimization – Target EOY Paying $2.1MM / annum in rent, taxes, utilities and insurance for an idled tubular asset in Munhall, PA. Actively seeking partners to purchase, assume lease or sublease. Asset was moved from DISCO in 2024, into remaining operating expenses part of Cont'd Ops in 2025. $2.1MM Annualized EBITDA Impact Tubular Asset Idled in 2023 \| Equipment Monetized in 2024 The Headline 13 Monetize Munhall Co n' t O pe ra tio ns Shut Down In 2023

------

![](acntir_16thannualmidwest014.jpg)

1H Existing Customer Expansion 1H New Customer Acquisition P RO J EC T CO U N T 5011% A N N UA L I Z E D R E V E N U E G ROW T H OV E R T T M S A L E S C YC L E 2.7 Months150% A N N UA L I Z E D A D J . E B I T DA G ROW T H OV E R T T M 1H2025 Pipeline Conversion (a n n u a l i z e d) (a n n u a l i z e d) EBITDA margin based on incremental gains, not total customer margin Stabilized; Focused on Unleashing Growth Designed entirely around the customer experience Delivered through technical expertise; scaled with discipline …Outcomes Over Everything 77% R E V E N U E G ROW T H F RO M E X I S T I N G C U S TO M E R S 35% E B I T DA M A RG I N CO N V E R S I O N R AT E 18% QoQ Selling Project Pipeline Growth (M USD) Q22025 Q12025 45.6% Increase 23% R E V E N U E G ROW T H F RO M N E W C U S TO M E R S 27% E B I T DA M A RG I N

------

![](acntir_16thannualmidwest015.jpg)

Simple and Clear EBITDA Drivers Management Turnaround  Structural cost savings with emphasis on strategic sourcing  Aggressive management of controllable spend  Discipline execution of overall equipment effectiveness (OEE)  Optimization of work processes & tools Organic Growth / Operating Leverage  Enhanced commercial strategy to grow share of higher- margin products  Increase plant utilization  Improve fixed cost absorption 4% 4% 9% 5% 22% \* Adj. EBITDA represents the standalone Chemical segment excluding Corporate Overhead 2023 ADJ. EBITDA % 2030 ADJ. EBITDA %2024 Mgmt. Turnaround Organic Growth / Operating Leverage Inorganic Growth Corp. Overhead, Inclusive of Public Company Costs ~7% 15 Completed & Achieved in 2024 Inorganic Growth  Searching for good businesses to make great  Leverage market and operational experience to unlock growth  Targeting $5-150M revenue and $0-$25M EBITDA

------

![](acntir_16thannualmidwest016.jpg)

And strong liquidity to support investor- friendly capital allocation priorities Every internal investment and acquisition is about accelerating progress, creating synergies that make sense, and delivering real, sustainable value. It's not only about size, it's about outcomes that matter, both strategically and operationally. Our goal is simple: to align every move with our mission and ensure it drives maximum impact for our shareholders. Financial Profile: $5-150MM Revenue \| $0-$25MM EBITDA Investment Type: Private or Publicly Held Asset Types: Specialty Chemicals Manufacturing, Distribution, Product Lines & Brands and Co-Packagers Target: Up to ~8X pre-synergy; up to ~6X post synergies M&A Investment Focus $0 ~$60M D E B T C A P A C I T Y ~$30M C A P A C I T Y T O I N V E S T ~$90M+ + = D E B T C A S H 16 Synergistic Platform Asset agility (reaction, formulation, blending & packaging) to insource product lines Disciplined cross-selling Proven ability to standardize, simplify and optimize all aspects of business operations Built-in M&A scalability engine Repurchased & Retired Nearly 6% of Outstanding Shares in Q22025

------

![](acntir_16thannualmidwest017.jpg)

Portfolio Optimized Strategic clarity. Focus. Efficiency. Stabilized and Growth Ready Predictability. Confidence. Credibility. Reduced risk. Growth Capacity In-Place Optionality. Scale. Margin. Growth. Resilience. Near-Term Upside Undervalued, leverage multiple upside. Strong Balance Sheet Stability. Strategic firepower for earnings-accretive M&A. Under-covered & Under Valued Early discovery can drive outsized investment returns when larger pools of capital follow. Why invest in ……the right people, proven together, trusted by each other, and aligned to win the next phase 17 ?

------

![](acntir_16thannualmidwest018.jpg)

Ryan Kavalauskas Chief Financial Officer rkavalauskas@ascentco.com 18 Ralf Esper Gateway Group, Inc. ACNT@gateway-grp.com

------

![](acntir_16thannualmidwest019.jpg)

Appendix 19

------

![](acntir_16thannualmidwest020.jpg)

Reconciliations of Non- GAAP Adjusted EBITDA FINANCIALS Three Months Ended June 30, Six Months Ended June 30, ($ in thousands) 2025 2024 2025 2024 Consolidated Net loss from continuing operations $(2,447) $(1,450) $(4,453) $(4,931) Adjustments: Interest expense, net (15) 72 99 199 Income taxes (89) (372) (89) (1,393) Depreciation 893 985 1,870 1,961 Amortization 153 179 306 348 EBITDA (1,505) (586) (2,267) (3,816) Acquisition costs and other 31 52 268 52 Asset impairments 1,622 — 1,622 — Gain on lease modification (544) — (544) — Stock-based compensation 86 44 120 93 Non-cash lease expense (25) 30 (1) 61 Retention expense — — — 3 Restructuring and severance cost — 177 — 177 Adjusted EBITDA $(335) $(283) $(802) $(3,430) % of sales (1.8) % (1.3) % (2.2) % (8.2) % Three Months Ended June 30, Six Months Ended June 30, ($ in thousands) 2025 2024 2025 2024 Specialty Chemicals Net income (loss) $1,499 $409 $2,237 $(1,049) Adjustments: Interest expense, net 15 20 32 39 Depreciation 878 964 1,840 1,918 Amortization 153 179 306 348 EBITDA 2,545 1,572 4,415 1,256 Acquisition costs and other — — 92 — Stock-based compensation — — — 7 Non-cash lease expense (5) 19 3 38 Restructuring and severance costs — 109 — 109 Specialty Chemicals Adjusted EBITDA $2,540 $1,700 $4,510 $1,410 % of segment sales 13.6 % 7.9 % 12.4 % 3.4 % Consolidated EBITDA and Adjusted EBITDA from continuing operations are as follows: Specialty Chemicals EBITDA and Adjusted EBITDA are as follows: 20

------